newsfilter
← Latest News
PR Newswire·

Spyre Therapeutics Added to the Nasdaq Biotechnology Index

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic...